MMJ Group Holdings Ltd (ASX:MMJ, OTC:MMJJF) has given its tacit agreement to an offer from BevCanna Enterprises Inc to acquire its investee Embark Health.

Embark Health is a Canada-based cannabis extraction business that has been making solid strategic business progress throughout 2021 as it eyes off a public listing, while BevCanna is a health & wellness beverage and natural products business listed on the Canadian Stock Exchange.

MMJ’s investment in Embark consists of shares and the current value stands at approximately C$2.4 million. MMJ expects that its share of the deal would approximate the current book value of its investment.

 BDSA announced today an update of its cannabis market forecast, a five-year rolling global forecast by country, state, province, channel, and category. Cannabis sales for 2021 will near $31 billion, an increase of 41% over 2020 sales. Further, BDSA forecasts global cannabis sales to grow from $30.6 billion in 2021 to $62.1 billion in 2026, a compound annual growth rate (CAGR) of more than 15%.

“The cannabis industry continues to show exceedingly rapid growth, particularly within the U.S. market,” said Kelly Nielsen, Vice President Insights & Analytics, BDSA. “New markets, both medical and adult-use, are developing at a faster pace than observed in the past, and states are transitioning from medical-only to fully legal in a shorter time frame.”

A North American company has turned to the crowdfunding scene to raise cash for its hemp bioplastics venture.Canadian Industrial Hemp Corporation (CIHC) has so far raised more than $1 million of a $5 million dollar target that will go towards building a factory to mass-produce plastic pellets made from agricultural waste – including hemp.The company says it has patent-pending technology featuring artificial intelligence to reduce cost and improve quality compared to existing global competitors, but that it would use high-throughput automated equipment already in use across Europe and Asia.

What would be North America’s first hemp plastic pellet production facility would replace imports from Europe and the facility will also produce hemp fiber.

 The enactment of adult-use marijuana sales in Canada is not associated with any increase in motor vehicle injuries requiring hospitalization, according to data published in the journal Drug and Alcohol Dependence. 

A team of investigators affiliated with the Centre for Addiction and Mental Health and with University of British Columbia assessed emergency department records in two provinces (Alberta and Ontario) to determine trends in traffic-injury emergency department visits in the months immediately prior to and immediately after legalization. 

In October 2018, Canada became the first G20 country to legalize the recreational use of cannabis. Over the past three years, the province of Ontario — to name just one Canadian jurisdiction — has moved away from having a significantly under-serviced retail market to one that is heavily saturated.

The Cannabis Act (Bill C-45) provided the rules and regulations around the production, distribution, sale and possession of cannabis. However, there are significant differences in each province’s and territory’s retail framework — private, public or hybrid — and the legal age for consumption, purchasing options and personal possession limits.

After the markets close Sept. 21, Aurora Cannabis (NASDAQ:ACB) will release results for its fiscal fourth quarter, which ended June 30. The troubled Canadian pot company's stock is already down by about 20% year to date -- a sharp contrast to the sector benchmark Horizons Marijuana Life Sciences ETF, which is up 5% -- and the upcoming report could be pivotal in determining whether the share price gets out of the red for 2021. Investors aren't expecting to see Aurora turn a profit in the final quarter of its fiscal year, but there are other ways that the company can show it is making progress. Here are the three main areas you should keep a close eye on when the company reports next week.

For those of you looking at how Canada makes CBD oil, this is the article for you.

CBD oil is how most CBD products are made. While we can take CBD oil on its own, it’s much better if we take it in the form of a tincture, a gummy bear, a vape juice, or cream. But how is CBD oil made? To explain that, we have a guide explaining just that.

Choosing the Extraction Method

The first step to make CBD oil is to decide on how to extract the cannabidiol from hemp. Hemp is the plant from which Canadians source cannabidiol. The plant is rich in cannabidiol and low on THC. This makes it perfect for extracting the compound and turning it into oil.

Tilray Inc (NASDAQ: TLRY) sent an open letter on August 26 from Irwin D. Simon, CEO and chairman, to the company’s shareholders. In the letter, Simon describes his vision for the company and gives his $4 billion target. He also encourages shareholders to vote for initiatives that are in line with this vision at Tilray’s special meeting of stockholders. The meeting is scheduled to occur on September 10. Tilray is one of the largest cannabis lifestyle and consumer-packaged goods companies in the world. It has operations in the U.S, Latin America, Canada, Europe and Australia. Tilray’s production platform supports about 20 brands in over 20 countries.

As the laws regarding cannabis are changing across the states and in other countries around the world, more people are starting to discover the benefits of the weed along with the variety of products and derivatives that come from it.

As legal dispensaries open up across Canada and the states, medical marijuana, along with recreational cannabis and CBD products, are easier to obtain than ever. However, there can be confusion as to what all these different products do, and how best they can be used. Indeed, there may be benefits to marijuana that you don’t even know.

This article will try to explain some of the differences between the products available today, the different ways that they can be used, and the health benefits when applicable.